Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 04, 2015 9:44 AM ET

Capital Markets

Company Overview of Novartis Venture Fund

Company Overview

Novartis Venture Fund is an evergreen fund. It is stage agnostic but specializes in investment in seed, early stage, and later stage investments but can also invest in other stages. It focuses on Series A and B for initial investment. The fund prefers to invest in product-and platform-focused biotech, pharmaceutical, medical devices and diagnostics, and healthcare sectors. The fund primarily invests in companies based in the United States and Europe. As the initial or follow-on investments, it typically invests between $10 million and $20 million. It typically takes a 25 percent (app) stake in its portfolio companies along with taking a board seat. It can also make follow on investments depe...

Postfach

Basel,  4002

Switzerland

Founded in 1996

Phone:

41 61 324 32 67

Fax:

41 61 324 86 79

Key Executives for Novartis Venture Fund

Managing Director
Age: 38
Managing Director
Compensation as of Fiscal Year 2015.

Novartis Venture Fund Key Developments

Novartis Venture Fund Presents at Bio-Trinity, May-11-2015

Novartis Venture Fund Presents at Bio-Trinity, May-11-2015 . Venue: Novotel London West, 1 Shortlands, London W6 8DR, United Kingdom.

Novartis Venture Fund Presents at The 15th annual New York Venture Summit 2015, Jun-24-2015

Novartis Venture Fund Presents at The 15th annual New York Venture Summit 2015, Jun-24-2015 . Venue: The Digital Sandbox, 55 Broad Street 4th Floor, New York, NY 10004, United States. Speakers: Christine Brennan, Principal.

Novartis Venture Fund Presents at BIO-Europe Spring 2015, Mar-09-2015 04:00 PM

Novartis Venture Fund Presents at BIO-Europe Spring 2015, Mar-09-2015 04:00 PM. Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France. Speakers: Anja König, Managing Director.

Similar Private Companies By Industry

Company Name Region
Finarbit AG Europe
On Finance SA Europe
CommCept AG Europe
Soditic S.A. Europe
Moravia Capital AG Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
July 10, 2015
Ra Pharmaceuticals, Inc.
Private Placement
July 7, 2015
GenSight Biologics SA
Private Placement
May 29, 2015
Kanyos Bio, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Novartis Venture Fund, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.